Effects of the storage conditions on the stability of natural and synthetic cannabis in biological matrices for forensic toxicology analysis: An update from the literature

Add links
BFAI
Clinical data
ATC code
  • none
Identifiers
  • 6,7-dihydro-5H-cyclopenta[f][1]benzofuran-6-amine
PubChem CID
Chemical and physical data
FormulaC11H11NO
Molar mass173.215 g·mol−1
3D model (JSmol)
  • C1C(CC2=C1C=C3C=COC3=C2)N
  • InChI=1S/C11H11NO/c12-10-4-8-3-7-1-2-13-11(7)6-9(8)5-10/h1-3,6,10H,4-5,12H2
  • Key:SYCRQDBZPIEBIR-UHFFFAOYSA-N

BFAI (5,6-Benzofuranyl-2-aminoindane) is a drug that acts as a serotonin releasing agent (SSRA) and produces entactogen effects in humans, which may be useful for psychotherapeutic applications. It is closely related to MDAI but with the benzodioxole ring system replaced by benzofuran.[1]

See also

References

  1. ^ WO 2022/032147, Baggott M, "2-Aminoindane compounds for mental disorders or enhancement.", published 10 February 2022, assigned to Tactogen Inc.